Skip to main content
. 2020 Apr 25;72(6):829–837. doi: 10.1002/acr.23892

Table 2.

Experiences and satisfaction of axial SpA patients with current SGE in 4 regions in The Netherlandsa

Overall (n = 118) R1 (n = 43) R2 (n = 17) R3 (n = 35) R4 (n = 23) P b
Overall intensity
Too high 11/112 (9.8) 4/41 (9.8) 0/14 (0) 5/34 (14.7) 2/23 (8.7) 0.43
Just right 84/112 (75) 31/41 (75.6) 11/14 (78.6) 27/34 (79.4) 15/23 (65.2) 0.71
Too low 17/112 (15.2) 6/41 (14.6) 3/14 (21.4) 2/34 (5.9) 6/23 (26.1) 0.18
Overall duration
Minutes 115 135 100 135 90
Too long 9/111 (8.1) 5/41 (12.2) 1/15 (6.7) 3/32 (9.4) 0/23 (0) 0.39
Just right 93/111 (83.8) 36/41 (87.8) 12/15 (80) 28/32 (87.5) 17/23 (73.9) 0.64
Too short 9/111 (8.1) 0/41 (0) 2/15 (13.3) 1/32 (3.1) 6/23 (26.1) 0.001
Overall load
Too heavy 15/117 (12.8) 6/43 (14) 1/17 (5.9) 4/34 (11.4) 4/23 (17.4) 0.73
Just right 89/117 (76.1) 31/43 (72.1) 12/17 (70.6) 29/34 (82.9) 17/23 (73.9) 0.67
Too easy 13/117 (11.1) 6/43 (14) 4/17 (23.6) 1/34 (2.9) 2/23 (9.7) 0.13
Mobility exercises
Too much attention 2/114 (1.8) 0/41 (0) 0/15 (0) 2/35 (5.7) 0/23 (0) 0.19
Just right attention 102/114 (89.5) 37/41 (90.2) 11/15 (73.3) 32/35 (91.4) 22/23 (95.7) 0.03
Too little attention 10/114 (8.8) 4/41 (9.8) 4/15 (26.7) 1/35 (2.9) 1/23 (4.3) 0.07
Strengthening exercises
Too much attention 1/115 (0.9) 0/42 (0) 0/15 (0) 1/35 (2.9) 0/23 (0) 0.50
Enough attention 90/115 (78.3) 32/42 (76.2) 11/15 (73.3) 28/35 (80) 19/23 (82.6) 0.55
Too little attention 24/115 (20.9) 10/42 (23.8) 4/15 (26.7) 6/35 (17.1) 4/23 (17.4) 0.88
Cardiorespiratory exercises
Too much attention 1/114 (0.9) 1/42 (2.4) 0/15 (0) 0/35 (0) 0/22 (0) 0.62
Enough attention 82/114 (71.9) 29/42 (69) 11/15 (73.3) 28/35 (80) 14/22 (63.6) 0.37
Too little attention 31/114 (27.2) 12/42 (28.6) 4/15 (26.7) 7/35 (20) 8/22 (36.4) 0.64
Opportunities personal exercise
Too little 18/116 (15.5) 9/43 (20.9) 0/16 (0) 4/35 (11.4) 5/22 (22.7) 0.15
Sufficient 49/116 (42.2) 20/43 (46.5) 9/16 (56.3) 11/35 (31.4) 9/22 (40.9) 0.41
Not necessary 49/116 (42.2) 14/43 (32.6) 7/16 (43.8) 20/35 (57.1) 8/22 (36.4) 0.15
Experienced effects
No deterioration 96/118 (81.4) 32/43 (74.4) 14/17 (82.4) 29/35 (82.9) 21/23 (91.3) 0.40
Less stiffness 70/118 (59.3) 26/43 (60.5) 11/17 (64.7) 16/35 (45.7) 17/23 (73.9) 0.18
More endurance 31/118 (26.3) 13/43 (30.2) 5/17 (29.4) 8/35 (22.9) 5/23 (21.7) 0.83
Less pain 23/118 (19.5) 10/43 (23.3) 3/17 (17.6) 6/35 (17.1) 4/23 (17.4) 0.89
More strength 21/118 (17.8) 7/43 (16.3) 3/17 (17.6) 6/35 (17.1) 5/23 (21.7) 0.96
Less medication 20/118 (16.9) 9/43 (20.9) 2/17 (11.8) 6/35 (17.1) 3/23 (13) 0.79
Other 34/118 (28.8) 14/43 (32.6) 8/17 (47.1) 7/35 (20) 5/23 (21.7) 0.18
None 4/118 (3.4) 2/43 (4.7) 0/17 (0) 2/35 (5.7) 0/23 (0) 0.53
SGE grade
Median (IQR) 7 (7–8) 8 (7–8) 7 (6–8) 8 (7–8) 7 (7–8) 0.47
Grade ≥7 103/118 (87.2) 36/43 (83.7) 12/17 (70.6) 34/35 (97.2) 20/23 (91.2) 0.04
a

Values are the number/total number (%) of participants unless indicated otherwise. SpA = spondyloarthritis; SGE = supervised group exercise; IQR = interquartile range.

b

P value of chi‐square test for categorical data and of one‐way analysis of variance for continuous data. P < 0.05 indicates a significant difference between the 4 regions.